Skip to main content

ADVERTISEMENT

lung cancer

Interview
02/06/2015
Our colleagues in surgical, medical, and radiation oncology still need to be made aware of the efficacy and application of ablation.Consider a 65-year-old female patient presenting to the local thoracic multidisciplinary conference with a...
Our colleagues in surgical, medical, and radiation oncology still need to be made aware of the efficacy and application of ablation.Consider a 65-year-old female patient presenting to the local thoracic multidisciplinary conference with a...
Our colleagues in surgical,...
02/06/2015
IO Learning
Interview
12/05/2013

Ronald S. Winokur, MD, and David C. Madoff, MD

From the Division of Interventional Radiology, New York-Presbyterian Hospital/Weill Cornell Medical Center. Correspondence to: David C. Madoff, MD, 525 East 68th Street, Payson 5, New York, NY 10065; email: dcm9006@med.cornell.edu

 

Ronald S. Winokur, MD, and David C. M...
Multidisciplinary care teams have been utilized throughout the world for many years to improve patient care and treatment planning by combining the expertise of multiple specialists. The US National Guideline Clearinghouse lists over 2,700...
Multidisciplinary care teams have been utilized throughout the world for many years to improve patient care and treatment planning by combining the expertise of multiple specialists. The US National Guideline Clearinghouse lists over 2,700...
Multidisciplinary care teams...
12/05/2013
IO Learning
09/11/2013

Jonathan Weinstein, MD, John H. Rundback, MD, Jordan Anaokar, MD, Kevin Herman, MD

From the Interventional Institute, Holy Name Medical Center, Teaneck, NJ.

Jonathan Weinstein, MD, John H. Rundb...
  Primary non-small cell lung cancer (NSCLC) causes more deaths in the United States per year than the combined mortality of breast, colon, and prostate cancer.1 For newly diagnosed patients, the 5-year overall survival rate is 15%. Due...
  Primary non-small cell lung cancer (NSCLC) causes more deaths in the United States per year than the combined mortality of breast, colon, and prostate cancer.1 For newly diagnosed patients, the 5-year overall survival rate is 15%. Due...
  Primary non-small cell...
09/11/2013
IO Learning